DOPAMET

This brand name is authorized in Cyprus, Hong Kong

Active ingredients

The drug DOPAMET contains one active pharmaceutical ingredient (API):

1 Alphamethyldopa
UNII 56LH93261Y - METHYLDOPA

Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.

Read about Alphamethyldopa

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DOPAMET Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C02AB01 Methyldopa (levorotatory) C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa
Discover more medicines within C02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: HK Department of Health Drug Office Identifier(s): 33821

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.